Research Letter: Limited additional serious adverse events associated with concomitant immunomodulatory treatment in people with atypical psychiatric disease.

IF 4 2区医学 Q1 PSYCHIATRY

Australian and New Zealand Journal of Psychiatry Pub Date : 2024-11-01 Epub Date: 2024-09-03 DOI:10.1177/00048674241271969

Parisa Fani-Molky, Jocelyn Jiang, Sabrina Naz, David Brown, Anthony Harris

引用次数: 0

查看原文本刊更多论文

研究信：与非典型精神病患者同时接受免疫调节剂治疗相关的额外严重不良事件有限。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Australian and New Zealand Journal of Psychiatry 医学-精神病学

CiteScore

8.00

自引率

2.20%

发文量

149

审稿时长

6-12 weeks

期刊介绍： Australian & New Zealand Journal of Psychiatry is the official Journal of The Royal Australian and New Zealand College of Psychiatrists (RANZCP). The Australian & New Zealand Journal of Psychiatry is a monthly journal publishing original articles which describe research or report opinions of interest to psychiatrists. These contributions may be presented as original research, reviews, perspectives, commentaries and letters to the editor. The Australian & New Zealand Journal of Psychiatry is the leading psychiatry journal of the Asia-Pacific region.